Literature DB >> 20960277

Primary hyperparathyroidism in Taiwan: clinical features and prevalence in a single-center experience.

Han-Hsiang Chen1, Yu-Wei Chen, Chih-Jen Wu.   

Abstract

In Taiwan, urolithiasis remains a common manifestation of primary hyperparathyroidism (PHPT). We designed this study to estimate the prevalence of PHPT in asymptomatic adults and to assess the complications already present when the disease was diagnosed. In the first phase of the study, we retrospectively reviewed 50 patients diagnosed with surgically or biochemically proven PHPT between April 1995 and April 2007. In the second phase, we reviewed the records of 4,359 asymptomatic subjects who had undergone a health examination between August 2002 and January 2007. Of the 50 patients reviewed in the first phase, hypercalcemia was the presenting complication in 33 patients (64%) followed by symptomatic recurrent solitary urolithiasis in 10 patients (20%). Of the 43 patients who underwent urologic imaging, 29 (67%) had urolithiasis and 7 (16%) had nephrocalcinosis, indicating that urinary stone disease is common. In the second phase, 28 of the 4,359 asymptomatic adults (0.64%) were found to have hypercalcemia; of these 28, 4 (0.092%) were diagnosed with PHPT. In Taiwan, PHPT remains underdiagnosed, and complications manifest in most patients upon admission. Although still relatively uncommon, screening serum calcium levels helps diagnose PHPT at an asymptomatic stage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960277     DOI: 10.1007/s12020-010-9315-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  21 in total

Review 1.  [Surgical indications of primary hyperparathyroidism].

Authors:  Yoshihiro Tominaga
Journal:  Clin Calcium       Date:  2005-12

Review 2.  Surgical treatment of primary hyperparathyroidism: from bilateral neck exploration to minimally invasive surgery.

Authors:  M R Pelizzo; C Pagetta; A Piotto; N Sorgato; I Merante Boschin; A Toniato; G Grassetto; D Rubello
Journal:  Minerva Endocrinol       Date:  2008-02-22       Impact factor: 2.184

Review 3.  Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum.

Authors:  Munro Peacock
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

4.  The role of routine intravenous urography in patients with primary hyperparathyroidism.

Authors:  A L Hine; C W Heron; R V Thakker; M Chapman
Journal:  Clin Radiol       Date:  1987-07       Impact factor: 2.350

Review 5.  Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features.

Authors:  J P Bilezikian; M L Brandi; M Rubin; S J Silverberg
Journal:  J Intern Med       Date:  2005-01       Impact factor: 8.989

6.  Primary hyperparathyroidism: a review of 177 cases.

Authors:  Sepehr Hamidi; Akbar Soltani; Anushiravan Hedayat; Nasser Kamalian
Journal:  Med Sci Monit       Date:  2006-01-26

7.  Clinical and laboratory profile of primary hyperparathyroidism in India.

Authors:  G Priya; V P Jyotsna; N Gupta; S Chumber; C S Bal; A K Karak; A Seth; A C Ammini
Journal:  Postgrad Med J       Date:  2008-01       Impact factor: 2.401

8.  Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

Authors:  H Heath; S F Hodgson; M A Kennedy
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

9.  Infrequency of primary hyperparathyroidism in renal stone formers.

Authors:  M Fuss; T Pepersack; J Corvilain; J C Vandewalle; J Van Geertruyden; J Simon; P Kinnaert
Journal:  Br J Urol       Date:  1988-07

Review 10.  Primary hyperparathyroidism and parathyroid hormone-related protein.

Authors:  M J Horwitz; J P Bilezikian
Journal:  Curr Opin Rheumatol       Date:  1994-05       Impact factor: 5.006

View more
  6 in total

1.  Difference between CKD-EPI and MDRD equations in calculating glomerular filtration rate in patients with cirrhosis.

Authors:  Yu-Wei Chen; Han-Hsiang Chen; Tsang-En Wang; Ching-Wei Chang; Chen-Wang Chang; Chih-Jen Wu
Journal:  World J Gastroenterol       Date:  2011-10-28       Impact factor: 5.742

2.  Parathyroid incidentalomas detected during thyroid ultrasonography and effect of chronic thyroiditis on false positive parathyroid lesions.

Authors:  Didem Ozdemir; Dilek Arpaci; Rifki Ucler; Neslihan Cuhaci; Reyhan Ersoy; Bekir Cakir
Journal:  Endocrine       Date:  2012-05-23       Impact factor: 3.633

3.  131I treatment for thyroid cancer and risk of developing primary hyperparathyroidism: a cohort study.

Authors:  Chien-Mu Lin; Pat Doyle; Yu-Tse Tsan; Chang-Hsing Lee; Jung-Der Wang; Pau-Chung Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-28       Impact factor: 9.236

4.  Eucalcemic parathyroid hormone elevation after parathyroidectomy for primary sporadic hyperparathyroidism: risk factors, trend, and outcome.

Authors:  Brian Hung-Hin Lang; Ian Yu-Hong Wong; Kai Pun Wong; Chung-Yau Lo
Journal:  Ann Surg Oncol       Date:  2011-07-06       Impact factor: 5.344

5.  Primary hyperparathyroidism: 11-year experience in a single institute in Thailand.

Authors:  Poramaporn Prasarttong-Osoth; Pakpong Wathanaoran; Waraporn Imruetaicharoenchoke; Supakorn Rojananin
Journal:  Int J Endocrinol       Date:  2012-05-31       Impact factor: 3.257

6.  Characteristics of patients operated for primary hyperparathyroidism at university hospitals in Türkiye: differences among Türkiye's geographical regions.

Authors:  Turkay Kirdak; Nuh Zafer Canturk; Nusret Korun; Gokhan Ocakoglu
Journal:  Ann Surg Treat Res       Date:  2016-06-30       Impact factor: 1.859

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.